440 Topical phosphodiesterase 4 (PDE4) inhibitor crisaborole (crisa) improves skin transcriptomic and proteomic biomarkers of mild-to-moderate AD towards normal skin

Autor: Pavel, A., Del Duca, E., Cheng, J., Facheris, P., Estrada, Y., Cha, A., Werth, J., Bissonette, R., Nocka, K., Zang, C., Guttman-Yassky, E.
Zdroj: In Journal of Investigative Dermatology August 2022 142(8) Supplement:S75-S75
Databáze: ScienceDirect